Thangirala Sudha

1.7k total citations
46 papers, 1.2k citations indexed

About

Thangirala Sudha is a scholar working on Molecular Biology, Immunology and Allergy and Oncology. According to data from OpenAlex, Thangirala Sudha has authored 46 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 9 papers in Immunology and Allergy and 8 papers in Oncology. Recurrent topics in Thangirala Sudha's work include Cell Adhesion Molecules Research (9 papers), Radiopharmaceutical Chemistry and Applications (7 papers) and Angiogenesis and VEGF in Cancer (5 papers). Thangirala Sudha is often cited by papers focused on Cell Adhesion Molecules Research (9 papers), Radiopharmaceutical Chemistry and Applications (7 papers) and Angiogenesis and VEGF in Cancer (5 papers). Thangirala Sudha collaborates with scholars based in United States, Egypt and Taiwan. Thangirala Sudha's co-authors include Shaker A. Mousa, Noureldien H. E. Darwish, Dhruba J. Bharali, Paul J. Davis, Hung‐Yun Lin, Kavitha Godugu, Kenneth Morgan, Edward Nylen, Takuya Fujiwara and Klaus Wrogemann and has published in prestigious journals such as Blood, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Thangirala Sudha

45 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thangirala Sudha United States 23 655 214 177 149 129 46 1.2k
Chun A. Changou Taiwan 25 695 1.1× 238 1.1× 342 1.9× 191 1.3× 71 0.6× 41 1.3k
Yiwei Wang China 23 895 1.4× 253 1.2× 259 1.5× 207 1.4× 48 0.4× 75 1.6k
Maria Paprocka Poland 18 408 0.6× 232 1.1× 121 0.7× 151 1.0× 71 0.6× 54 936
Xiong Li China 19 562 0.9× 138 0.6× 93 0.5× 230 1.5× 51 0.4× 70 1.2k
Xiaochun Peng China 23 807 1.2× 490 2.3× 226 1.3× 321 2.2× 73 0.6× 74 1.8k
Eric Mas France 24 885 1.4× 378 1.8× 102 0.6× 336 2.3× 59 0.5× 60 1.7k
Gaurav Swarnkar United States 21 913 1.4× 223 1.0× 184 1.0× 124 0.8× 42 0.3× 39 1.4k
Yingqiu Xie Kazakhstan 27 1.1k 1.7× 505 2.4× 300 1.7× 139 0.9× 25 0.2× 80 2.0k
Tomohisa Yokoyama Japan 22 1.1k 1.6× 450 2.1× 269 1.5× 176 1.2× 74 0.6× 44 2.0k
Prasanthi Karna United States 16 629 1.0× 214 1.0× 255 1.4× 138 0.9× 143 1.1× 21 1.2k

Countries citing papers authored by Thangirala Sudha

Since Specialization
Citations

This map shows the geographic impact of Thangirala Sudha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thangirala Sudha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thangirala Sudha more than expected).

Fields of papers citing papers by Thangirala Sudha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thangirala Sudha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thangirala Sudha. The network helps show where Thangirala Sudha may publish in the future.

Co-authorship network of co-authors of Thangirala Sudha

This figure shows the co-authorship network connecting the top 25 collaborators of Thangirala Sudha. A scholar is included among the top collaborators of Thangirala Sudha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thangirala Sudha. Thangirala Sudha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Glinsky, Gennadi V., Kavitha Godugu, Thangirala Sudha, et al.. (2022). Effects of Anticancer Agent P-bi-TAT on Gene Expression Link the Integrin Thyroid Hormone Receptor to Expression of Stemness and Energy Metabolism Genes in Cancer Cells. Metabolites. 12(4). 325–325. 4 indexed citations
2.
Sudha, Thangirala, Taher A. Salaheldin, Noureldien H. E. Darwish, & Shaker A. Mousa. (2022). Antitumor/Anti-Angiogenesis Efficacy of Epigallocatechin Gallate Nanoformulated with Antioxidant in Melanoma. Nanomedicine. 17(15). 1039–1053. 11 indexed citations
3.
Darwish, Noureldien H. E., Gennadi V. Glinsky, Thangirala Sudha, & Shaker A. Mousa. (2022). Targeting Thyrointegrin αvβ3 Using Fluorobenzyl Polyethylene Glycol Conjugated Tetraiodothyroacetic Acid (NP751) in Acute Myeloid Leukemia. Frontiers in Oncology. 11. 793810–793810. 4 indexed citations
4.
Godugu, Kavitha, et al.. (2021). New Thyrointegrin αvβ3 Antagonist with a Scalable Synthesis, Brain Penetration, and Potent Activity against Glioblastoma Multiforme. Journal of Medicinal Chemistry. 64(9). 6300–6309. 11 indexed citations
5.
Nuñeza, Olga M., et al.. (2021). Anticancer Effects of the Corchorus olitorius Aqueous Extract and Its Bioactive Compounds on Human Cancer Cell Lines. Molecules. 26(19). 6033–6033. 14 indexed citations
6.
7.
Darwish, Noureldien H. E., Thangirala Sudha, Taher A. Salaheldin, et al.. (2021). Development of Triiodothyronine Polymeric Nanoparticles for Targeted Delivery in the Cardioprotection against Ischemic Insult. Biomedicines. 9(11). 1713–1713. 6 indexed citations
8.
Godugu, Kavitha, Thangirala Sudha, Paul J. Davis, & Shaker A. Mousa. (2021). Nano Diaminopropane tetrac and integrin αvβ3 expression in different cancer types: Anti-cancer efficacy and Safety. Cancer Treatment and Research Communications. 28. 100395–100395. 7 indexed citations
9.
Nada, Hanady G., Thangirala Sudha, Noureldien H. E. Darwish, & Shaker A. Mousa. (2020). Lactobacillus acidophilus and Bifidobacterium longum exhibit antiproliferation, anti-angiogenesis of gastric and bladder cancer: Impact of COX2 inhibition. PharmaNutrition. 14. 100219–100219. 19 indexed citations
10.
11.
Boukhatem, Mohamed Nadjib, et al.. (2020). A New Eucalyptol-Rich Lavender (Lavandula stoechas L.) Essential Oil: Emerging Potential for Therapy against Inflammation and Cancer. Molecules. 25(16). 3671–3671. 55 indexed citations
12.
Sudha, Thangirala, et al.. (2020). Resveratrol and Its Nanoformulation Attenuate Growth and the Angiogenesis of Xenograft and Orthotopic Colon Cancer Models. Molecules. 25(6). 1412–1412. 38 indexed citations
13.
14.
Sudha, Thangirala, et al.. (2020). αvβ3 Integrin Antagonists Enhance Chemotherapy Response in an Orthotopic Pancreatic Cancer Model. Frontiers in Pharmacology. 11. 95–95. 17 indexed citations
15.
Rajabi, Mehdi, Kavitha Godugu, Thangirala Sudha, Dhruba J. Bharali, & Shaker A. Mousa. (2019). Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol: High Affinity Thyrointegrin αvβ3 Antagonist with Potent Anticancer Activities in Glioblastoma Multiforme. Bioconjugate Chemistry. 30(12). 3087–3097. 23 indexed citations
16.
Darwish, Noureldien H. E., Thangirala Sudha, Kavitha Godugu, et al.. (2019). Novel Targeted Nano-Parthenolide Molecule against NF-kB in Acute Myeloid Leukemia. Molecules. 24(11). 2103–2103. 55 indexed citations
17.
Sudha, Thangirala, Dhruba J. Bharali, Stewart Sell, et al.. (2017). Nanoparticulate Tetrac Inhibits Growth and Vascularity of Glioblastoma Xenografts. Hormones and Cancer. 8(3). 157–165. 26 indexed citations
18.
Sudha, Thangirala, Dhruba J. Bharali, Murat Yalçın, et al.. (2017). Targeted delivery of paclitaxel and doxorubicin to cancer xenografts via the nanoparticle of nano-diamino-tetrac. International Journal of Nanomedicine. Volume 12. 1305–1315. 39 indexed citations
19.
Bharali, Dhruba J., Thangirala Sudha, Huadong Cui, Badar M. Mian, & Shaker A. Mousa. (2016). Anti-CD24 nano-targeted delivery of docetaxel for the treatment of prostate cancer. Nanomedicine Nanotechnology Biology and Medicine. 13(1). 263–273. 42 indexed citations
20.
Zheng, Xin, Fei Chu, Bernard L. Mirkin, et al.. (2008). Role of the proteolytic hierarchy between cathepsin L, cathepsin D and caspase-3 in regulation of cellular susceptibility to apoptosis and autophagy. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1783(12). 2294–2300. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chun A. Changou Breakdown of academic impact, for papers by Yiwei Wang Breakdown of academic impact, for papers by Maria Paprocka Breakdown of academic impact, for papers by Xiong Li Breakdown of academic impact, for papers by Xiaochun Peng Breakdown of academic impact, for papers by Eric Mas Breakdown of academic impact, for papers by Gaurav Swarnkar Breakdown of academic impact, for papers by Yingqiu Xie Breakdown of academic impact, for papers by Tomohisa Yokoyama Breakdown of academic impact, for papers by Prasanthi Karna
Rankless by CCL
2026